| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 14182363
[patent_doc_number] => 20190110886
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-18
[patent_title] => METHOD AND SYSTEM FOR PREPARING SOFT TISSUE FOR GRAFTING, ENHANCING GRAFTING RESULTS, AND GRAFTING AUTOLOGOUS FAT AND ADIPOCYTE DERIVED STEM CELLS TO SOFT TISSUE SUCH AS THE BREAST AND OTHER TISSUE DEFECTS
[patent_app_type] => utility
[patent_app_number] => 15/978657
[patent_app_country] => US
[patent_app_date] => 2018-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7376
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15978657
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/978657 | Methods and materials for augmenting a region of soft tissue | May 13, 2018 | Issued |
Array
(
[id] => 13533607
[patent_doc_number] => 20180318346
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-08
[patent_title] => IMMUNOMODULATORY PROPERTIES OF MAPCS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/970385
[patent_app_country] => US
[patent_app_date] => 2018-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23352
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15970385
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/970385 | Immunomodulatory properties of MAPCs and uses thereof | May 2, 2018 | Issued |
| 15/771324 | Compositions and Methods for Chimeric Embryo-Assisted Organ Production | Apr 26, 2018 | Abandoned |
Array
(
[id] => 15832377
[patent_doc_number] => 20200131470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-30
[patent_title] => METHOD FOR PRODUCING MESENCHYMAL STEM CELLS, THERAPEUTIC EFFECT MARKER OF MESENCHYMAL STEM CELLS, METHOD FOR DETERMINING THERAPEUTIC EFFECTS OF MESENCHYMAL STEM CELLS, AND CELLULAR PREPARATION CONTAINING MESENCHYMAL STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 16/607244
[patent_app_country] => US
[patent_app_date] => 2018-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22320
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16607244
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/607244 | METHOD FOR PRODUCING MESENCHYMAL STEM CELLS, THERAPEUTIC EFFECT MARKER OF MESENCHYMAL STEM CELLS, METHOD FOR DETERMINING THERAPEUTIC EFFECTS OF MESENCHYMAL STEM CELLS, AND CELLULAR PREPARATION CONTAINING MESENCHYMAL STEM CELLS | Apr 24, 2018 | Abandoned |
Array
(
[id] => 13493603
[patent_doc_number] => 20180298344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-18
[patent_title] => Realistic Humanized Model of Disease Matrix Environment for Evaluation of Therapeutic Reversal or Cell Fate
[patent_app_type] => utility
[patent_app_number] => 15/950354
[patent_app_country] => US
[patent_app_date] => 2018-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15982
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15950354
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/950354 | Realistic Humanized Model of Disease Matrix Environment for Evaluation of Therapeutic Reversal or Cell Fate | Apr 10, 2018 | Abandoned |
Array
(
[id] => 13476419
[patent_doc_number] => 20180289752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-11
[patent_title] => Spore-Based Probiotic Composition for Reduction of Dietary Endotoxemia and Related Methods
[patent_app_type] => utility
[patent_app_number] => 15/947521
[patent_app_country] => US
[patent_app_date] => 2018-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6670
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15947521
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/947521 | Spore-Based Probiotic Composition for Reduction of Dietary Endotoxemia and Related Methods | Apr 5, 2018 | Abandoned |
Array
(
[id] => 16320188
[patent_doc_number] => 10780135
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-22
[patent_title] => Probiotic formulation and method for weight loss treatment
[patent_app_type] => utility
[patent_app_number] => 15/946581
[patent_app_country] => US
[patent_app_date] => 2018-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2366
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15946581
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/946581 | Probiotic formulation and method for weight loss treatment | Apr 4, 2018 | Issued |
Array
(
[id] => 13488583
[patent_doc_number] => 20180295834
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-18
[patent_title] => CRYOPRESERVATION METHOD
[patent_app_type] => utility
[patent_app_number] => 15/945422
[patent_app_country] => US
[patent_app_date] => 2018-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13414
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15945422
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/945422 | CRYOPRESERVATION METHOD | Apr 3, 2018 | Abandoned |
Array
(
[id] => 15527701
[patent_doc_number] => 20200056156
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-20
[patent_title] => CELL POPULATION COMPRISING MESENCHYMAL STEM CELLS, METHOD FOR PRODUCING THE SAME, AND PHARMACEUTICAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/500261
[patent_app_country] => US
[patent_app_date] => 2018-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11814
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16500261
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/500261 | CELL POPULATION COMPRISING MESENCHYMAL STEM CELLS, METHOD FOR PRODUCING THE SAME, AND PHARMACEUTICAL COMPOSITION | Apr 2, 2018 | Abandoned |
Array
(
[id] => 15769329
[patent_doc_number] => 20200115682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-16
[patent_title] => Use of Engineered Liver Tissue Constructs for Modeling Liver Disorders
[patent_app_type] => utility
[patent_app_number] => 16/500521
[patent_app_country] => US
[patent_app_date] => 2018-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49523
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -95
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16500521
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/500521 | Use of engineered liver tissue constructs for modeling liver disorders | Apr 2, 2018 | Issued |
Array
(
[id] => 17801280
[patent_doc_number] => 11415574
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-16
[patent_title] => Lymphocyte-based morphometric test for alzheimer's disease
[patent_app_type] => utility
[patent_app_number] => 15/939948
[patent_app_country] => US
[patent_app_date] => 2018-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 4667
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15939948
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/939948 | Lymphocyte-based morphometric test for alzheimer's disease | Mar 28, 2018 | Issued |
Array
(
[id] => 13397597
[patent_doc_number] => 20180250341
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-06
[patent_title] => METHOD OF REPAIRING DAMAGED BLOOD-SPINAL CORD BARRIER (BSCB)
[patent_app_type] => utility
[patent_app_number] => 15/905522
[patent_app_country] => US
[patent_app_date] => 2018-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14112
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15905522
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/905522 | METHOD OF REPAIRING DAMAGED BLOOD-SPINAL CORD BARRIER (BSCB) | Feb 25, 2018 | Abandoned |
Array
(
[id] => 16808217
[patent_doc_number] => 20210130770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => NOVEL BIOMATERIAL SUBSTRATES, CELL CULTURE SYSTEMS COMPRISING THE SAME AND USES THEREOF IN CELL SCREENING APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 16/488397
[patent_app_country] => US
[patent_app_date] => 2018-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10738
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16488397
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/488397 | Biomaterial substrates, cell culture systems comprising the same and uses thereof in cell screening applications | Feb 22, 2018 | Issued |
Array
(
[id] => 13389113
[patent_doc_number] => 20180246099
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-30
[patent_title] => ISOLATION OF HUMAN LUNG PROGENITORS DERIVED FROM PLURIPOTENT STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 15/902614
[patent_app_country] => US
[patent_app_date] => 2018-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41444
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15902614
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/902614 | Isolation of human lung progenitors derived from pluripotent stem cells | Feb 21, 2018 | Issued |
Array
(
[id] => 15681755
[patent_doc_number] => 20200095541
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-26
[patent_title] => METHOD FOR PRODUCING CANCER STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 16/487247
[patent_app_country] => US
[patent_app_date] => 2018-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7871
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16487247
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/487247 | Method of producing cancer stem cells | Feb 19, 2018 | Issued |
Array
(
[id] => 14716133
[patent_doc_number] => 20190249130
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-15
[patent_title] => CELL EXPANSION VESSEL SYSTEMS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 15/893336
[patent_app_country] => US
[patent_app_date] => 2018-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7554
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 178
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15893336
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/893336 | Cell expansion vessel systems and methods | Feb 8, 2018 | Issued |
Array
(
[id] => 15738423
[patent_doc_number] => 20200108099
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-09
[patent_title] => THERAPEUTIC AGENT FOR PULMONARY FIBROSIS, PTPRR EXPRESSION-PROMOTOR, AND KIT FOR TREATMENT OF PULMONARY FIBROSIS
[patent_app_type] => utility
[patent_app_number] => 16/486438
[patent_app_country] => US
[patent_app_date] => 2018-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8566
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16486438
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/486438 | THERAPEUTIC AGENT FOR PULMONARY FIBROSIS, PTPRR EXPRESSION-PROMOTOR, AND KIT FOR TREATMENT OF PULMONARY FIBROSIS | Feb 8, 2018 | Abandoned |
Array
(
[id] => 15114511
[patent_doc_number] => 20190343888
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-14
[patent_title] => C-KIT-POSITIVE BONE MARROW CELLS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/481587
[patent_app_country] => US
[patent_app_date] => 2018-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17171
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16481587
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/481587 | C-KIT-POSITIVE BONE MARROW CELLS AND USES THEREOF | Jan 31, 2018 | Abandoned |
Array
(
[id] => 15813997
[patent_doc_number] => 10632155
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-28
[patent_title] => Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition
[patent_app_type] => utility
[patent_app_number] => 15/879042
[patent_app_country] => US
[patent_app_date] => 2018-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 72
[patent_no_of_words] => 29298
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15879042
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/879042 | Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition | Jan 23, 2018 | Issued |
Array
(
[id] => 15946079
[patent_doc_number] => 10660918
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-26
[patent_title] => Method for enhancing insulin like growth factor 1 receptor expression of mesenchymal stem cell, method for isolating mesenchymal stem cell, and use of mesenchymal stem cell
[patent_app_type] => utility
[patent_app_number] => 15/853989
[patent_app_country] => US
[patent_app_date] => 2017-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 48
[patent_no_of_words] => 10744
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15853989
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/853989 | Method for enhancing insulin like growth factor 1 receptor expression of mesenchymal stem cell, method for isolating mesenchymal stem cell, and use of mesenchymal stem cell | Dec 25, 2017 | Issued |